DGAP-Adhoc: PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA

DGAP-Ad-hoc: PAION AG / Key word(s): Contract
PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA

27-Apr-2022 / 16:33 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of...
Quelle: Börse Online RSS Feed